Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/15
End: 08/17/20
Due: 08/17/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma | NCT02507583 | david andrews | user2@example.com | None | 2015-09-01 | 2020-08-17 | 2021-08-17 | - | - | 2025-07-14 |